Compounds > docetaxel anhydrous
Page last updated: 2024-09-04

docetaxel anhydrous and Dysphagia

docetaxel anhydrous has been researched along with Dysphagia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Inaki, N; Kinoshita, J; Moriyama, H; Nakamura, K; Okamoto, K; Saito, H; Shimada, M; Tsuji, T; Yamaguchi, T1
Doki, Y; Hagi, T; Kimura, Y; Makino, T; Mori, M; Motoori, M; Nishida, N; Sakai, D; Satoh, T; Tanaka, K; Yamasaki, M1
Doki, Y; Kobayashi, T; Makino, T; Mori, M; Tanaka, K; Yamasaki, M1
Denaro, N; Merlano, MC; Russi, EG1
Alcindor, T; Asselah, J; Cools-Lartigue, J; Eckert, E; Ferri, LE; Jones, D; Rousseau, M; Spicer, J; Vanhuyse, M; Zourikian, T1
Aizawa, T; Ishibashi, N; Maebayashi, T; Saito, T; Sakaguchi, M1
Ellemann, AC; Kofoed, SC; Lundsgaard, M; Svendsen, LB1

Other Studies

7 other study(ies) available for docetaxel anhydrous and Dysphagia

ArticleYear
Impact of preoperative docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy on degree of malignant esophageal stenosis.
    BMC gastroenterology, 2023, Aug-18, Volume: 23, Issue:1

    Topics: Cisplatin; Constriction, Pathologic; Deglutition Disorders; Docetaxel; Esophageal Stenosis; Fluorouracil; Humans

2023
Dysphagia Score as a Predictor of Adverse Events Due to Triplet Chemotherapy and Oncological Outcomes in 434 Consecutive Patients with Esophageal Cancer.
    Annals of surgical oncology, 2019, Volume: 26, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deglutition Disorders; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Quality of Life; Retrospective Studies; Survival Rate

2019
Successful Stenting Followed by Surgery for Perforated Esophageal Cancer Due to Chemotherapy.
    The Annals of thoracic surgery, 2019, Volume: 108, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Contrast Media; Deglutition Disorders; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Perforation; Esophageal Stenosis; Esophagectomy; Fluorouracil; Follow-Up Studies; Humans; Male; Neoadjuvant Therapy; Risk Assessment; Stents; Tomography, X-Ray Computed; Treatment Outcome

2019
Strategies for non-resectable head and neck cancer.
    Current treatment options in oncology, 2013, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deglutition Disorders; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Patient Care Team; Patient Selection; Practice Patterns, Physicians'; Radiotherapy, Intensity-Modulated; Speech Disorders; Survival Analysis; Taxoids; Treatment Outcome

2013
Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided?
    Annals of surgical oncology, 2015, Volume: 22, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deglutition Disorders; Docetaxel; Enteral Nutrition; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Prospective Studies; Quality of Life; Taxoids

2015
Clinical Outcomes of Hypopharyngeal Cancer Receiving Definitive Radiotherapy with Concurrent Chemotherapy.
    Anticancer research, 2017, Volume: 37, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deglutition Disorders; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Mucositis; Multivariate Analysis; Neoplasm Staging; Neoplasms, Second Primary; Neutropenia; Radiotherapy Dosage; Retrospective Studies; Taxoids; Treatment Outcome

2017
Low morbidity after palliation of obstructing gastro-oesophageal adenocarcinoma to restore swallowing function.
    Danish medical journal, 2012, Volume: 59, Issue:6

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Argon Plasma Coagulation; Capecitabine; Carboplatin; Chemoradiotherapy; Combined Modality Therapy; Deglutition Disorders; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Esophageal Perforation; Esophagogastric Junction; Female; Fluorouracil; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Palliative Care; Prosthesis Failure; Retrospective Studies; Stents; Taxoids

2012